Literature DB >> 16037820

Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.

Valentina Fogal1, Jung-Kuang Hsieh, Christophe Royer, Shan Zhong, Xin Lu.   

Abstract

We show here that the cell cycle-dependent DNA-binding and transcriptional activity of p53 correlates with E2F expression in human primary fibroblasts. E2F1 binds and stimulates DNA-binding, transactivation and apoptotic functions of p53 but not p63 and p73. E2F1 binds residues 347-370 of p53 and enhances nuclear retention of Ser315 phosphorylated p53. This regulation of p53 by E2F1 is cell cycle dependent, as the cellular distribution of Ser315 phosphorylated p53 is associated with the periodic expression of E2F and cyclin A throughout the cell cycle. This is the first demonstration that the activities of p53 are regulated during the cell cycle by E2F/p53 interactions and that phosphorylation of p53 at Ser315 is required for this regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037820      PMCID: PMC1182237          DOI: 10.1038/sj.emboj.7600735

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Authors:  Harry A Rogoff; Mary T Pickering; Michelle E Debatis; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

2.  Tumor induction and tissue atrophy in mice lacking E2F-1.

Authors:  L Yamasaki; T Jacks; R Bronson; E Goillot; E Harlow; N J Dyson
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.

Authors:  T David-Pfeuty; F Chakrani; K Ory; Y Nouvian-Dooghe
Journal:  Cell Growth Differ       Date:  1996-09

4.  The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53.

Authors:  L Li; M Ljungman; J E Dixon
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.

Authors:  Jung-Kuang Hsieh; Damian Yap; Daniel J O'Connor; Valentina Fogal; Lynn Fallis; Florence Chan; Shan Zhong; Xin Lu
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.

Authors:  Y Zhang; Y Xiong
Journal:  Science       Date:  2001-06-08       Impact factor: 47.728

7.  E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

Authors:  J K Hsieh; S Fredersdorf; T Kouzarides; K Martin; X Lu
Journal:  Genes Dev       Date:  1997-07-15       Impact factor: 11.361

8.  ARF differentially modulates apoptosis induced by E2F1 and Myc.

Authors:  Jamie L Russell; John T Powers; Robert J Rounbehler; Pamela M Rogers; Claudio J Conti; David G Johnson
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

9.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Authors:  Y Li; C W Jenkins; M A Nichols; Y Xiong
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

10.  Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

Authors:  D J O'Connor; E W Lam; S Griffin; S Zhong; L C Leighton; S A Burbidge; X Lu
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  20 in total

Review 1.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

Review 2.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

3.  Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.

Authors:  M K Lee; W M Tong; Z Q Wang; K Sabapathy
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

4.  Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line.

Authors:  Sakae Maeda; Hiroshi Wada; Yoko Naito; Hiroaki Nagano; Szandor Simmons; Yoshinori Kagawa; Atsushi Naito; Junichi Kikuta; Taeko Ishii; Yoshito Tomimaru; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Hidetoshi Eguchi; Koji Umeshita; Hideshi Ishii; Yuichiro Doki; Masaki Mori; Masaru Ishii
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

5.  Essential amino acid supplementation alters the p53 transcriptional response and cytokine gene expression following total knee arthroplasty.

Authors:  Jonathan B Muyskens; Ari Winbush; Douglas M Foote; Douglas W Turnbull; Hans C Dreyer
Journal:  J Appl Physiol (1985)       Date:  2020-09-03

Review 6.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

7.  Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.

Authors:  Elizabeth A Slee; Barbara Benassi; Robert Goldin; Shan Zhong; Indrika Ratnayaka; Giovanni Blandino; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

Review 8.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

Authors:  Giulia Fontemaggi; Stefania Dell'Orso; Daniela Trisciuoglio; Tal Shay; Elisa Melucci; Francesco Fazi; Irene Terrenato; Marcella Mottolese; Paola Muti; Eytan Domany; Donatella Del Bufalo; Sabrina Strano; Giovanni Blandino
Journal:  Nat Struct Mol Biol       Date:  2009-09-27       Impact factor: 15.369

Review 10.  Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Authors:  Xiaohong Wang; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.